chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm, Soreness; red rash; bright red area at the injection site; At the injection site itchy; painful; Rash on wrist and ankle; Atopic dermatitis; It looks like it's stuffy and really hot; vaccination site warmth to touch; dry skin; At the injection site itchy; painful; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration on 12Feb2021 (at the age of 67-years-old) as 1st dose, single for COVID-19 immunisation.  Medical history included anxiety, kidney stone disease, high blood pressure, cholesterol, dermatitis. Concomitant medications included hydrochlorothiazide, lisinopril and alprazolam (XANAX), all taken for an unspecified indication, start and stop date were not reported. Concomitant medications included also other unspecified drugs. On 28Feb2021 (reported also as 8 days after the 12th, so probably around 28th) the patient experienced sore arm, soreness, red rash, bright red area at the injection site, at the injection site itchy; painful, rash on wrist and ankle, atopic dermatitis, it looks like it's stuffy and really hot (hot flush), vaccination site warmth to touch and dry skin. The patient reported that she had the first Pfizer covid 19 vaccine on 12Feb2021 and her next dose on 05Mar2021. Patient reported a sore arm ,a bright red area at the injection site and itching. Patient clarified that it was not a rash at the injection site. Patient reported a rash on her wrist and ankles that her doctor said was dry skin because she did not have a dry skin problem. Patient stated the redness was still there but not as bright and did not itch as much. She broke into a pretty significant red rash; redness at the injection site. At the injection site itchy; painful. The patient stated that she had reaction or whatever it was at the vaccine site; it was warm to the touch; extensive itching. It looks like it's stuffy and really hot. She developed a very itchy rash on wrist and ankle. The patient stated that she has been signed to get the vaccine again but she still had a little bit of redness there. The patient stated that at time of reporting it's better it's just red, a little red, it's not as itchy, it's improving, it's subcutaneous you know, it is not what it was before and it's not as hot as it was before. The events were treated with Antihistamine. Patient reported that it was also simultaneous and unrelated also at the same time developed a very itchy rash on wrist and ankle her doctor said that was different, she had dermatitis issue probably from dry skin so he gave her anti-histamine for that, taken for a couple of days. The outcome of events was unknown.   No follow-up attempts are possible. No further information is expected.
Similar to first dose: Significant aches in joints and pain in arm with injection making sleep difficult. Ongoing.  Last time, soreness lasted about 3 days but was tolerable.  Different side effects from first dose: Painful headache with significant nausea. I never threw up but had dry heaves for 3-4 hours. These symptoms appear to have subsided.
This medically confirmed spontaneous report (initial receipt: 28-Sep-2012) concerns a female patient. On 25-Sep-2012 the patient received AFLURIA PFS (batch number: P59808) injection. Following vaccination, the patient developed injection site reactions. The reaction was described as being localised at the injection site 3 inches in diameter, red, hot and hard to the touch. The patient sought medical attention. The event outcome was recovering.
2:30am cst I woke up in a lot of pain. My whole body was being racked by wave after wave of muscle soreness. Anything that touched my bed hurt. I tried sitting up, turning over side to side, and the pain continued. This was accompanied by a severe chill that caused my teeth to rattle. The apartment was set to 68 which is slightly warm to me. I got up to go to the restroom and my legs grew tired almost immediately. I?ve tried laying back down and getting back up 2 more times. The chill and the pain have continued now for 3 hours and 17 minutes, although the chill has diminished to a mild child instead of severe. No notable fever has been measured thus far.
underage patient received the first Moderna dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage patient received the first Moderna dose) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage patient received the first Moderna dose). On 23-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (underage patient received the first Moderna dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Observed patient touching throat attempting to clear throat. Offered water. Thru translation from family patient states she is experiencing scratchy throat. Hx of seafood allergies. Benadrly 50 mg Im left deltoid. B/B elevated. Observed for another 30minutes. Patient appears anxious.  Rash and scratch throat has subsided. Patient verbalized relief.  Advised pt to visit PCP tomorrow for follow up about elevated BP.
I  fever 102.2 , weakness, fitage , chills, head aches  and arm sores. 48  hours recovered.
Sore arm, chills, fever, joint aches, lethargy, tiredness, lack of appetite lasting 36 hours
An initial report was received from a nurse on 12.Dec.2012 and concerns an 18-year-old female who, on 08.Dec.2012, received the first administration of VIVOTIF (batch no: 3000261). The patient's medical history and concomitant medications were not reported. On 08.Dec.2012, the evening following the first administration of VIVOTIF, the patient experienced severe abdominal cramps. The patient took the second dose of VIVOTIF on 10.Dec.2012 and the cramps continued. No further information was reported. At the time of reporting, the outcome of the event was unknown. The event was considered to be non-serious.
Initial unsolicited report received from a physician on 29 June 2015. A female patient (age not reported), whose medical history and concomitant medication were not reported, had received a dose of TDAP (batch number: U4886AA, expiration date: 29 October 2016, dose and dose number were not reported) intramuscularly in right deltoid on 29 August 2014. On an unspecified date post-vaccination, the patient experienced tingling and numbness at injection site, up and down arm and neck with discomfort and pain. Physician characterized as paresthesia. Laboratory investigation and corrective treatment were not reported. At the time of this report, the outcome of the event was unknown. Follow up information received from a consumer on 13 August 2051. The age of patient was 52 years (age reported as 53 years). On 31 August 2014, two days after vaccination, patient experienced the adverse events. At the time of this report, the patient had not recovered from the above mentioned events. Documents held by sender: none.
I could not move my arm, I got a really bad headache, and bodyaches for three days
Severe headache; Body ache in back and especially lower back; Body ache in hips; Fever of 100-102; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. The patient had no known previous history of COVID-19.  Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 10 mg daily for unknown indication and from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Mar2021 at 15:00 (two days after receiving vaccine), the patient experienced severe headache, body ache in back and especially lower back and hips, and fever of 100-102 (unit unspecified) every day and continuing for 10 days (still ongoing to some extent). The symptoms got improve with treatment Tylenol but fever keeps returning. It ranges in severity; headache cleared after about 5 days but back pain, hip pain and fever come and go. On 25Mar2021, the patient had nasal swab (Novel coronavirus COVID-19 nasal/nasopharynx) test and resulted negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure was taken as a result of events and included treatment with acetaminophen (TYLENOL). The clinical outcome of the events severe headache was resolved on 26Mar2021 (cleared after about 5 days); while that of the events fever, back pain and pain in hips was resolving (come and go) at the time of this report.  No follow-up attempts are needed. No further information is expected.
Nausea, vomiting, generalized weakness for 1 week.  Patient states she had covid in January 2021 and recovered.  Patient discovered to have urinary tract infection and is admitted to the hospital for this reason.
Had sore arm ( same day of injection & day after) A little fatigue 24 hours after Most of the symptoms came 6-7 days after injection. - One day of complete fatigue. Hives on arm near injection site 7 days after.  Nausea, upper back & neck pain & major headaches. Symptoms lasted another 7 days after. Symptoms were so strong has COVID test, but was negative.  Didn't feel totally better until 14 days after vaccine.
Local reaction left upper thigh 8 cm circular area-erythemia and heat painful to touch-afebrile-T 97.8-no restriction of ambulation-tylenol to reduce inflammation
5 hours after vaccine administration, he developed fever to 101.6, chills, swelling (no redness) at site, headaches and general body aches.
broke out with hives behind ears, thoracic region and belly region, a couple behind knees and on arms; This case was reported by a consumer via call center representative and described the occurrence of generalized urticaria in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th January 2021, the patient received the 1st dose of Shingrix (intramuscular). On 28th January 2021, 1 days after receiving Shingrix, the patient experienced generalized urticaria. On an unknown date, the outcome of the generalized urticaria was recovered/resolved.   It was unknown if the reporter considered the generalized urticaria to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself. The patient received the Shingrix shot into the left arm. The patient broke out with hives behind ears, thoracic region and belly region and a couple behind knees and on arms. They presented the next day and lasted for about a week.  The reporter consented to follow up. For tolerance to the 2nd Shingrix shot, refer case US2021AMR061693.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021061360:same reporter US-GLAXOSMITHKLINE-US2021AMR061693:same patient
Information has been received from a nurse concerning a patient (demographics unknown) who on 11-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck). On 28-APR-2008, the patient developed shingles. At the time of the report, the patient's shingles persisted. Unspecified medical attention was sought. Additional information has been requested.
This spontaneous report as received from a nurse refers to a 9 months 1 day old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
The day after the injection I was not able to lift my arm (right) above my shoulder due to pain. After approximately one week I could not lift it to drink without the help of my other hand. An orthopedic doctor has since told me that the injection / needle struck a blood vessel and nerve. Brachial Neuritus? Due to compensating for the pain I stressed other areas / inflammation of rotator cuff / bicepital tendonitus. Received cortisone injection 7/11/07.  11 physical therapy treatments / 11 chiropractic treatments / MRI / xrays / 2 acupuncture treatments / 1 massage therapy / 3 orthopedic appts / purchase of TENS unit.  Previous to injection on April 12, 2007 I swam 3 days / week and lifted moderate weights.  By mid August the pain had subsided. I still am not to the level of swimming or moderate weight lifting that I was prior to the injection.  There is still a ... "click" in my shoulder.  I sent a letter to the clinic on May 16 2007 stating my concerns.  I did not get a reply.   Twice I made appointments with Clinic Administrator and both times he was "not available".
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diphtheria crml97 protein) injection) was received from a nurse practitioner, the mother of a 6 month old male patient who received his first dose of Prevnar in the spring of 2000, and developed an allergic reaction characterized by " a hive at the injeciton site", covered from head to toe with "1 large hive" and dry scaly skin over a large area of his body. Mediacal History: the pt concurrent illness includes thrombocytopenia (with normal count of 70,000 to 80,0000) and a past medical history of hypersensitivity (mother reported that pt outgrew allergy to strawberries). The reporter indicated that there were no other allergies. Event Details: The pt received his first dose of Prevnar in the spring of 2000. One hour post-vaccination, he developed a large allergic reaction characterized by " a hive at the injection site" one inch in diameter. Five hours post vaccination, the pt was covered  from head to toe with "one large hive" The reporter stated " the hive lasted 3 days even though the child was treated with Benadryl elixer (dose unknown). Two days post vaccination the "hive" had occurred. The pt recovery status is unknown. No additonal information was available at the time of this report.
Nauseated, dizziness, unwell, feeling hot and her throat felt funny. Adminstered Epipen on opposite upper arm at 12:20PM.
PATIENT HAD RED RASHY AREAS ON HER BODY, NOT ITCHY, STARTING THE DAY AFTER VACCINATION. HER DR. GAVE HER A COURSE OF PREDNISONE AND SHE IS DOING GOOD NOW
Information has been downloaded from regulatory authority (US-SEQIRUS-201802318). This spontaneous report was received from a health professional and refers to a 18 year old female patient. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided. On 29-SEP-2017, the patient was vaccinated with GARDASIL 9 1 dosage form (DF), intramuscular (anatomical location, lot # and expiration date were not provided), and with FLUVIRIN 0.5 ml, intramuscular, lot # 1720701 (anatomical location and expiration date were not provided) both vaccines for an unknown indication. On the same date, the patient experienced loss of consciousness and syncope. The outcome of loss of consciousness and syncope was reported as recovered on an unknown date. The causality between the events loss of consciousness and syncope and the suspect therapies was not reported. The agency considered loss of consciousness and syncope to be medically significant events.
tingling of lips, followed by lips swelling, followed by face flushing and swelling and back of throat "itchy".  Developed over an hour, subsided in about two hours after taking an Allegra 180 mg.
This individual is an EMS first responder who volunteers within our EMS system. She arrived at our clinic during a event to receive a vaccination. Unfortunately, she was advised that she could receive a vaccine with her mothers consent by our County Emergency Manager. A consent was obtained and she was lead to the clinic injection area. Once there, her consent form was reviewed and all of her screening questions were checked no. At this point in time, on the first day, we did not include a yes/no question confirming everyone was over 18 because its was only select recipients.  The mistake was noticed immediatly and reported to the recipients mother who was also on site. It was explained the vaccine administered does not have an EUA for 16-18 year-olds. The county OMD was also notified at this time. The recipient did not have any reactions post inoculation. A followup call was placed later in the day to confirm she still did not experience any signs or symptoms, which she had not.  We where able to identify the root cause of this event and have implemented a number of new safety measures to ensure we do not have a repeat event.
Have been actively bleeding outside of my menstrual period, since 2 days after receiving the vaccination. Today is day 7.
Moderna-COVID19 Vaccine EUA.  Right and left hands had blue color in all joints and both index/thumbs. Saw discoloration around 10 am on 2/11/2020 one day after the 1st vaccine. My hands were very cold as well. Discoloration lasted throughout the day. Saw my doctor at 3:20pm, same day, and given no history of Reynaud's Syndrome determined event was side effect was of vaccine. Discoloration went away by 8:00 p.m. that evening.
about 20 mins after admin, she reported frontal Headache and photosensitivity. then  30 mins after that reported general pruritis and chest tightness. Vital signs were stable throughout, WNL BP and pulse and SAO2 consistently >95%.
Employee indicates within 15 minutes of receiving FLU vaccine she developed itchy eyes, runny nose, mild airway tightness, congestion and cough, used prescribed as amacort in haler and by mouth CLARITIN (per employee takes ibuprofen prophylactically, prior to injections for injection site erythema).
Abnormal, severe menstrual cramping, excessively heavy bleeding, passing of very large clots
Moderna vaccine was administered - reported by patient  J96.00 ACUTE RESPIRATORY FAILURE 5/16/2022 DYSPNEA ON EXERTION R09.02 HYPOXIA 5/16/2022 DYSPNEA ON EXERTION
This spontaneous report was received from a patient of unknown age and gender. On 04-SEP-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). Approximately on an unknown date in September 2013, the patient experienced rash around the injection site, headaches and also mouth (reported as mouth) and teeth pain. The outcome of the event was unknown. Causality was not reported. Consumer did not want to provide any additional information. Additional information is not expected.
Chills, redness, swelling, 100.4 temp, could not lift arm, joint pain and swelling; 7-23-08 Began having pain in joints of (R) arm and (L) leg; red eye.
Pain in shoulder when raising arm. No treatment. Just hurts when arm is raised straight out. Taking off shirt hurts shoulder.
This spontaneous consumer report (initial receipt: 01-Nov-2011) concerns a 60-year old female patient. Concomitant medication included a multivitamin. Last year the patient received a flu and PNEUMOVAX 23 shot into the same arm for flu and pneumonia prevention. About 24 to 48 hours later, the patient had soreness and tenderness in the arm that received the injections. She went to the physician and was diagnosed with cellulitis. She was given an antibiotic. The cellulitis resolved about a week later.
This spontaneous report as received from a registered nurse who refers to unspecified patients of unknown age. On unspecified dates, since 15-JUL-2016, patients were vaccinated with PEDVAXHIB lot # M020100, expiration date 07-MAR-2019 and lot # M027882, expiration date 14-APR-2019. The registered nurse reported that doses of improperly stored PEDVAXHIB lot # M020400, expiration date 07-MAR-2019 and lot # M027882, expiration date 14-APR-2019 have been administered to unspecified patients on unspecified dates since 15-JUL-2016. Temperature and Time frame: 48.2F for 12 minutes. There were no previous temperature excursion. The call was placed because of a "data logger". No adverse event have been reported. Additional information has been requested.
within 15': flushed, nauseated, throat swelling. dizzy., tachycardia  Transferred to ED:  treated with Benadryl. solumedrol. sx resolved. Observed for 4 hrs. d/cd to home